MannKind Up 20% On Diabetes Deal With Sanofi

By: via Benzinga
Shares of MannKind (NASDAQ: MNKD) are up more than 18 percent in pre-market trading. This move is on the back of the announcement by ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.